Published in Arch Ophthalmol on June 13, 2011
Nitroglycerin for Intra-arterial Chemotherapy in Pediatric Retinoblastoma. | NCT04564521
Retinoblastoma: achieving new standards with methods of chemotherapy. Indian J Ophthalmol (2015) 2.05
Update on intra-arterial chemotherapy for retinoblastoma. ScientificWorldJournal (2014) 1.15
Retinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapy. Eye (Lond) (2012) 1.06
Combined, sequential intravenous and intra-arterial chemotherapy (bridge chemotherapy) for young infants with retinoblastoma. PLoS One (2012) 1.03
Pathological findings in enucleated eyes after intravitreal melphalan injection. Int Ophthalmol (2013) 1.00
Intravitreal injection of melphalan for intraocular retinoblastoma. Jpn J Ophthalmol (2015) 0.99
Electroretinogram monitoring of dose-dependent toxicity after ophthalmic artery chemosurgery in retinoblastoma eyes: six year review. PLoS One (2014) 0.97
Ophthalmic artery chemosurgery for less advanced intraocular retinoblastoma: five year review. PLoS One (2012) 0.92
Understanding pRb: toward the necessary development of targeted treatments for retinoblastoma. J Clin Invest (2012) 0.91
Superselective intra-arterial melphalan therapy for newly diagnosed and refractory retinoblastoma: results from a single institution. Clin Ophthalmol (2013) 0.91
Retinoblastoma. Fifty years of progress. The LXXI Edward Jackson Memorial Lecture. Am J Ophthalmol (2014) 0.91
Orthotopic transplantation of retinoblastoma cells into vitreous cavity of zebrafish for screening of anticancer drugs. Mol Cancer (2013) 0.90
Use of intra-arterial chemotherapy for retinoblastoma: results of a survey. Int J Ophthalmol (2014) 0.90
Intra-arterial chemotherapy for advanced retinoblastoma: is the time right for a prospective clinical trial? Arch Ophthalmol (2011) 0.85
Outcome of retinoblastoma following limited sessions of intra-arterial chemotherapy in iran. Iran J Radiol (2014) 0.81
Validating a nonhuman primate model of super-selective intraophthalmic artery chemotherapy: comparing ophthalmic artery diameters. Invest Ophthalmol Vis Sci (2012) 0.81
Combined intravitreal melphalan and intravenous/intra-arterial chemotherapy for retinoblastoma with vitreous seeds. Graefes Arch Clin Exp Ophthalmol (2015) 0.81
Selective ophthalmic arterial injection of melphalan for intraocular retinoblastoma: a 4-year review. Jpn J Ophthalmol (2014) 0.81
Retinoblastoma major review with updates on Middle East management protocols. Saudi J Ophthalmol (2012) 0.81
Superselective intraophthalmic artery chemotherapy in a nonhuman primate model: histopathologic findings. JAMA Ophthalmol (2013) 0.79
Retinoblastoma: Recent trends A mini review based on published literature. Oman J Ophthalmol (2011) 0.78
Long-Term Outcomes of Group B Eyes in Patients with Retinoblastoma Treated with Short-Course Chemoreduction: Experience from Children's Hospital Los Angeles/University of Southern California. Ocul Oncol Pathol (2015) 0.77
The role of intravitreal chemotherapy for retinoblastoma. Indian J Ophthalmol (2015) 0.76
Conservative treatment of retinoblastoma: a prospective phase II randomized trial of neoadjuvant chemotherapy followed by local treatments and chemothermotherapy. Eye (Lond) (2015) 0.76
Verification of supraselective drug delivery for retinoblastoma using intra-arterial gadolinium. BMJ Case Rep (2012) 0.75
Recent trends in ocular oncology. Oman J Ophthalmol (2011) 0.75
Longitudinal trends in use of targeted therapies for treatment of malignant neoplasms of the eye: a population-based study in Taiwan. BMJ Open (2016) 0.75
Recent advances and challenges in the management of retinoblastoma. Indian J Ophthalmol (2017) 0.75
Ocular tumors: Triumphs, challenges and controversies. Saudi J Ophthalmol (2013) 0.75
A review of the literature for intra-arterial chemotherapy used to treat retinoblastoma. Pediatr Radiol (2016) 0.75
Ocular Salvage and Vision Preservation Using a Topotecan-Based Regimen for Advanced Intraocular Retinoblastoma. J Clin Oncol (2016) 0.75
Tumors of the conjunctiva and cornea. Surv Ophthalmol (2004) 3.03
Ocular tuberculosis masquerading as ocular tumors. Surv Ophthalmol (2004) 2.69
Intermittent and chronic ultraviolet light exposure and uveal melanoma: a meta-analysis. Ophthalmology (2005) 2.55
Optical coherence tomography in children: analysis of 44 eyes with intraocular tumors and simulating conditions. J Pediatr Ophthalmol Strabismus (2004) 2.53
Orbital tumors in the older adult population. Ophthalmology (2002) 2.40
Clinical survey of 1643 melanocytic and nonmelanocytic conjunctival tumors. Ophthalmology (2004) 2.32
Endovascular treatment of proximal and distal posterior inferior cerebellar artery aneurysms. J Neurosurg (2013) 2.23
American Joint Committee on Cancer (AJCC) clinical classification predicts conjunctival melanoma outcomes. Ophthal Plast Reconstr Surg (2012) 2.17
Factors predictive of tumor growth, tumor decalcification, choroidal neovascularization, and visual outcome in 74 eyes with choroidal osteoma. Arch Ophthalmol (2005) 2.17
Rapid and progressive venous thrombosis after occlusion of high-flow arteriovenous fistula. World Neurosurg (2012) 2.17
Iris nevus growth into melanoma: analysis of 1611 consecutive eyes: the ABCDEF guide. Ophthalmology (2013) 2.13
Vitreous hemorrhage after plaque radiotherapy for uveal melanoma. Retina (2012) 2.06
Incidence of pineal gland cyst and pineoblastoma in children with retinoblastoma during the chemoreduction era. Am J Ophthalmol (2013) 2.02
Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation. Am J Ophthalmol (2002) 1.99
Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes. Arch Ophthalmol (2009) 1.89
The International Classification of Retinoblastoma predicts chemoreduction success. Ophthalmology (2006) 1.86
Conjunctival melanoma: outcomes based on tumor origin in 382 consecutive cases. Ophthalmology (2010) 1.86
Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma. Am J Ophthalmol (2002) 1.83
Uveal metastasis from breast cancer in 264 patients. Am J Ophthalmol (2003) 1.80
Lumbar adjacent segment degeneration and disease after arthrodesis and total disc arthroplasty. Spine (Phila Pa 1976) (2008) 1.73
Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors. Am J Ophthalmol (2004) 1.70
Treatment of retinal capillary hemangioma. Ophthalmology (2002) 1.70
Treatment of posterior circulation aneurysms with the pipeline embolization device. Neurosurgery (2013) 1.69
Chromosome 3 analysis of uveal melanoma using fine-needle aspiration biopsy at the time of plaque radiotherapy in 140 consecutive cases: the Deborah Iverson, MD, Lectureship. Arch Ophthalmol (2007) 1.68
Choroidal nevus transformation into melanoma: analysis of 2514 consecutive cases. Arch Ophthalmol (2009) 1.64
Long-term visual outcome following chemoreduction for retinoblastoma. Arch Ophthalmol (2005) 1.62
Intra-arterial chemotherapy for retinoblastoma: report No. 2, treatment complications. Arch Ophthalmol (2011) 1.61
Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma. Ophthalmology (2011) 1.61
Diagnosis and management of retinoblastoma. Cancer Control (2004) 1.60
Impact of a standardized protocol and antibiotic-impregnated catheters on ventriculostomy infection rates in cerebrovascular patients. Neurosurgery (2010) 1.56
Simultaneous eyelid and choroidal metastases 36 years after diagnosis of medullary thyroid carcinoma. Ophthal Plast Reconstr Surg (2008) 1.56
Optical coherence tomography of retinal astrocytic hamartoma in 15 cases. Ophthalmology (2006) 1.54
Stent-assisted coiling of intracranial aneurysms: predictors of complications, recanalization, and outcome in 508 cases. Stroke (2013) 1.54
Neovascular glaucoma from advanced Coats disease as the initial manifestation of facioscapulohumeral dystrophy in a 2-year-old child. Arch Ophthalmol (2007) 1.53
Irradiation toxic effects during intra-arterial chemotherapy for retinoblastoma: should we be concerned? Arch Ophthalmol (2010) 1.53
Dural arteriovenous fistulas: a review of the literature and a presentation of a single institution's experience. World Neurosurg (2012) 1.50
Potential financial impact of restriction in "never event" and periprocedural hospital-acquired condition reimbursement at a tertiary neurosurgical center: a single-institution prospective study. J Neurosurg (2010) 1.49
Coiling of ruptured aneurysms followed by evacuation of hematoma. World Neurosurg (2010) 1.48
Is packing density important in stent-assisted coiling? Neurosurgery (2012) 1.47
Risk of hemorrhagic complication associated with ventriculoperitoneal shunt placement in aneurysmal subarachnoid hemorrhage patients on dual antiplatelet therapy. J Neurosurg (2013) 1.46
Postenucleation adjuvant therapy in high-risk retinoblastoma. Arch Ophthalmol (2002) 1.45
Sources of variability in computed tomography perfusion: implications for acute stroke management. Neurosurg Focus (2011) 1.44
Autofluorescence of treated retinoblastoma. J AAPOS (2011) 1.44
Stent-assisted endovascular recanalization of extracranial internal carotid artery occlusion in acute ischemic stroke. World Neurosurg (2012) 1.44
Conjunctival nevi: clinical features and natural course in 410 consecutive patients. Arch Ophthalmol (2004) 1.43
Tight glycemic control reduces infection and improves neurological outcome in critically ill neurosurgical and neurological patients. Neurosurgery (2012) 1.43
Conjunctival edema and distichiasis in association with congenital lymphedema of the lower legs. Ophthal Plast Reconstr Surg (2009) 1.41
Enhanced depth imaging optical coherence tomography of small choroidal melanoma: comparison with choroidal nevus. Arch Ophthalmol (2012) 1.41
Clinical spectrum of diffuse infiltrating retinoblastoma in 34 consecutive eyes. Ophthalmology (2008) 1.40
Assessment of anterior segment tumors with ultrasound biomicroscopy versus anterior segment optical coherence tomography in 200 cases. Ophthalmology (2011) 1.39
Iris cavernous hemangioma associated with multiple cavernous hemangiomas in the kidney, brain, and skin. Cornea (2007) 1.38
Bilateral optic disk melanocytoma in a 10-month-old infant. Am J Ophthalmol (2003) 1.38
Enhanced depth imaging optical coherence tomography of choroidal nevus in 104 cases. Ophthalmology (2012) 1.38
Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma. Arch Ophthalmol (2002) 1.35
Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy. Curr Opin Ophthalmol (2010) 1.35
Interferon for ocular surface squamous neoplasia in 81 cases: outcomes based on the American Joint Committee on Cancer classification. Cornea (2013) 1.34
Comparison of flow diversion and coiling in large unruptured intracranial saccular aneurysms. Stroke (2013) 1.33
Iris cysts: a review. Semin Ophthalmol (2011) 1.31
Optical coherence tomography of choroidal osteoma in 22 cases: evidence for photoreceptor atrophy over the decalcified portion of the tumor. Ophthalmology (2007) 1.31
Conjunctival amyloidosis: report of six cases and review of the literature. Surv Ophthalmol (2006) 1.30
Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases. Retina (2012) 1.28
Iris involvement by lymphoma: a review of 13 cases. Clin Experiment Ophthalmol (2013) 1.28
Photodynamic therapy for choroidal metastasis in 8 cases. Ophthalmology (2012) 1.27
Endovascular management of intracranial aneurysms: current experience and future advances. Neurosurgery (2006) 1.27
Regression of extrafoveal choroidal osteoma following photodynamic therapy. Arch Ophthalmol (2008) 1.26
Effect of early surgery, material, and method of flap preservation on cranioplasty infections: a systematic review. Neurosurgery (2011) 1.26
Outcomes of anti-vascular endothelial growth factor therapy in the management of choroidal neovascularization associated with choroidal osteoma. Retina (2014) 1.25
Combined hamartoma of the retina and retinal pigment epithelium in 77 consecutive patients visual outcome based on macular versus extramacular tumor location. Ophthalmology (2008) 1.25
Basic understanding of current classification and management of retinoblastoma. Curr Opin Ophthalmol (2006) 1.25
Review of optical coherence tomography for intraocular tumors. Curr Opin Ophthalmol (2005) 1.24
Peripheral exudative hemorrhagic chorioretinopathy simulating choroidal melanoma in 173 eyes. Ophthalmology (2009) 1.24
Plaque radiotherapy for large posterior uveal melanomas (> or =8-mm thick) in 354 consecutive patients. Ophthalmology (2002) 1.23
Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification. Arch Ophthalmol (2012) 1.22
Iodine I 125 plaque radiotherapy for vasoproliferative tumors of the retina in 30 eyes. Arch Ophthalmol (2008) 1.21
Optical coherence tomographic findings of combined hamartoma of the retina and retinal pigment epithelium in 11 patients. Arch Ophthalmol (2005) 1.21
Ocular melanoma: relatively rare but requiring respect. Clin Dermatol (2008) 1.21
Congenital simple hamartoma of the retinal pigment epithelium: a study of five cases. Ophthalmology (2003) 1.20
The association between host susceptibility factors and uveal melanoma: a meta-analysis. Arch Ophthalmol (2006) 1.19